Document Type : Original Article

Authors

1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

2 Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

3 Professor, Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

4 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

5 Associate Professor, Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

10.30476/smsj.2024.103116.1547

Abstract

Introduction: In recent years, there has been a growth in the demand for skincare services and products. In this study, a topical formulation composed of glutathione loaded into niosomes was developed, and its physical, chemical, and microbial characteristics were evaluated.
Methods: Span 60 was used to prepare niosomes, and glutathione was added to the formulation using the incorporation method. Drug assays were performed using high-performance liquid chromatography (HPLC). The physicochemical characteristics of the prepared niosomes and their drug-release properties were investigated. Carbomer and sodium carboxymethyl cellulose were used to form gels, and stability tests were performed.
Results: HPLC demonstrated a linear relationship in the concentration range of 10-100 µg/mL. Morphological studies showed that niosomes had spherical structures. The majority of the medication was released through polymer degradation, and a small amount was released through the diffusion mechanism. Rheological analysis revealed that the fabricated gels had thixotropic and pseudoplastic properties. None of the samples showed changes in color or odor during this period. The formulation underwent microbiological analysis, and no specific microorganisms were found.
Conclusion: The developed formulation exhibited acceptable properties in vitro. Therefore, further in vivo research should be conducted to determine the efficacy of the formulation.

Keywords

  1. Wollina U, Payne CR. Aging well--the role of minimally invasive aesthetic dermatological procedures in women over 65. J Cosmet Dermatol. 2010;9(1):50-8.
  2. de Araújo R, Lôbo M, Trindade K, Silva DF, Pereira N. Fibroblast growth factors: a controlling mechanism of skin aging. Skin pharmacology and physiology. 2019;32(5):275-82.
  3. Imokawa G. Epithelial-mesenchymal interaction mechanisms leading to the over-expression of neprilysin are involved in the UVB-induced formation of wrinkles in the skin. Exp Dermatol. 2016;25 Suppl 3:2-13.
  4. Ige S, Akhigbe R, Akinsanya A. The role of hyperglycemia in skin wrinkle formation: Mediation of advanced glycation end-products. Research Journal of Medical Sciences. 2010;4(5):324-9.
  5. Desai SR. Hyperpigmentation therapy: a review. The Journal of clinical and aesthetic dermatology. 2014;7(8):13.
  6. Alanzi ME, Alghamdi RA, Alsharif OM, Alghamdi KS, El Sayed SM. Health Knowledge, Cosmetic Interests, Attitude, and the Need for Health Education Regarding the Use of Topical Bleaching Agents Among Women in West Saudi Arabia: A Cross-Sectional Study. J Cosmet Sci. 2018;69(2):101-20.
  7. Olumide YM. Use of skin lightening creams. British Medical Journal Publishing Group; 2010.
  8. Wang W, Ballatori N. Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev. 1998;50(3):335-56.
  9. Dilokthornsakul W, Dhippayom T, Dilokthornsakul P. The clinical effect of glutathione on skin color and other related skin conditions: A systematic review. J Cosmet Dermatol. 2019;18(3):728-37.
  10. Malathi M, Thappa DM. Systemic skin whitening/lightening agents: what is the evidence? Indian Journal of Dermatology, Venereology and Leprology. 2013;79:842.
  11. Nakajima H, Nagata T, Koga S, Imokawa G. Reduced glutathione disrupts the intracellular trafficking of tyrosinase and tyrosinase-related protein-1 but not dopachrome tautomerase and Pmel17 to melanosomes, which results in the attenuation of melanization. Arch Dermatol Res. 2014;306(1):37-49.
  12. Kovacs-Nolan J, Rupa P, Matsui T, Tanaka M, Konishi T, Sauchi Y, et al. In vitro and ex vivo uptake of glutathione (GSH) across the intestinal epithelium and fate of oral GSH after in vivo supplementation. Journal of agricultural and food chemistry. 2014;62(39):9499-506.
  13. Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ. Nanotechnology: a focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol. 2006;1(3):340-50.
  14. Kavussi HR, Miresmaeili SM, Lotfabadi NN. Niosomes from Preparation to Application in Drug Delivery. Journal of Shahid Sadoughi University of Medical Sciences. 2020.
  15. Allen L, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems: Lippincott Williams & Wilkins; 2013.
  16. Kaur G, Grewal J, Jyoti K, Jain UK, Chandra R, Madan J. Oral controlled and sustained drug delivery systems: Concepts, advances, preclinical, and clinical status. Drug targeting and stimuli sensitive drug delivery systems: Elsevier; 2018. p. 567-626.
  17. Behra JS, Mattsson J, Cayre OJ, Robles ES, Tang H, Hunter TN. Characterization of sodium carboxymethyl cellulose aqueous solutions to support complex product formulation: A rheology and light scattering study. ACS Applied Polymer Materials. 2019;1(3):344-58.
  18. Alanazi AM, Mostafa GA, Al-Badr AA. Glutathione. Profiles Drug Subst Excip Relat Methodol. 2015;40:43-158.
  19. Ahuja N, Saini V, Bishnoi VK, Garg A, Hisoria M, Sharma J, et al. Formulation and evaluation of lansoprazole niosome. Rasayan J Chem. 2008;1(3):561-3.
  20. Ourani-Pourdashti S, Mirzaei E, Heidari R, Ashrafi H, Azadi A. Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. Int J Biol Macromol. 2022;213:1115-26.
  21. Jahanbekam S, Mozafari N, Bagheri-Alamooti A, Mohammadi-Samani S, Daneshamouz S, Heidari R, et al. Ultrasound-responsive hyaluronic acid hydrogel of hydrocortisone to treat osteoarthritis. Int J Biol Macromol. 2023;240:124449.
  22. Ijaz N, Durrani AI, Rubab S, Bahadur S. Formulation and characterization of Aloe vera gel and tomato powder containing cream. Acta Ecologica Sinica. 2022;42(2):34-42.
  23. Yeo PL, Lim CL, Chye SM, Ling APK, Koh RY. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomedicine. 2017;11(4):301-14.
  24. Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol. 2005;18(5):209-19.
  25. Ghasemiyeh P, Azadi A, Daneshamouz S, Heidari R, Azarpira N, Mohammadi-Samani S. Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting. Pharm Dev Technol. 2019;24(7):812-23.
  26. Ruwizhi N, Aderibigbe BA. The Efficacy of Cholesterol-Based Carriers in Drug Delivery. Molecules. 2020;25(18).
  27. Elmas A, Akyüz G, Bergal A, Andaç M, Andaç Ö. Mathematical modelling of drug release. Research on Engineering Structures and Materials. 2020;6(4).
  28. Kaur LP. Topical gel: a recent approach for novel drug delivery. Asian journal of biomedical and Pharmaceutical Sciences. 2013;3(17):1.
  29. Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015;22(8):1027-42.
  30. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19(6):296-302.
  31. Macosko CW. Rheology principles. Measurements and Applications. 1994.
  32. Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences: Lippincott Williams & Wilkins; 2023.